Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Su

Orthopaedic Surgery of the Spine Larkspur, CA Medical Doctor

NPI 1063690782 CMS profile 48411

2 Bon Air Rd, Suite 120, Larkspur, CA 94939

Open in the dashboard

General payments

$65,562

349 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Su of Larkspur, CA is reported in the CMS Open Payments database as having received $65,562 across 349 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,612 42
2024 General $6,246 33
2023 General $7,913 52
2022 General $4,984 56
2021 General $9,409 89
2020 General $2,908 38
2019 General $16,490 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Su
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Brian Su were reported at $17,612. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Brian Su Orthopaedic Surgery of the Spine median Middle half National median
2019 $16,490 $2,106 $337–$18,608 $163
2020 $2,908 $1,213 $156–$15,082 $114
2021 $9,409 $1,834 $271–$15,617 $132
2022 $4,984 $2,015 $320–$17,036 $149
2023 $7,913 $1,925 $336–$14,599 $160
2024 $6,246 $2,110 $341–$12,483 $164
2025 $17,612 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $13,267 27 payments
  2. BIOTRONIK NRO, Inc. $12,537 16 payments
  3. Spineart USA Inc $12,304 43 payments
  4. Alphatec Spine, Inc $10,198 108 payments
  5. CoreLink, LLC $5,614 12 payments
  6. DePuy Synthes Sales Inc. $2,257 38 payments
  7. Abbott Laboratories $1,172 10 payments
  8. Globus Medical, Inc. $828 5 payments
  9. GS Solutions, Inc. $651 1 payment
  10. Medtronic, Inc. $531 5 payments
  11. Other $6,203 84 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $26,238 4 payments
  2. Food and Beverage $23,579 294 payments
  3. Travel and Lodging $15,635 49 payments
  4. Gift $100 1 payment
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10 1 payment
Products named General payments · program years 2019–2025
  1. Prospera $12,370 16 payments
  2. TRITANIUM $11,296 3 payments
  3. XIA $11,000 1 payment
  4. Other - Miscellaneous $4,154 24 payments
  5. PERLA C $3,337 8 payments
  6. MULTIPLE $1,360 5 payments
  7. SCARLET AL-T $1,308 5 payments
  8. IdentiTi $1,078 21 payments
  9. YUKON $838 8 payments
  10. Proclaim IPG $805 7 payments
  11. Other $16,120 217 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

156

Median for Orthopedic Surgery: 203

Drug cost

$1,264

Median for Orthopedic Surgery: $1,433

Branded share of claims

11.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 50 $466
Oxycodone Hcl Generic 47 $365
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $265
Tramadol Hcl Generic 16 $79
Prednisone Generic 13 $57
Lorazepam Generic 12 $32

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$296,577

Medicare's payments for the services billed

Medicare patients

600

Average age 75

Services billed

1,697

307 women, 293 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Ischemic heart disease 28%
Osteoporosis 23%
Depression 20%
Diabetes 17%
Atrial fibrillation 17%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

349 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record